Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Pedro De-Marchi"'
Autor:
Pedro Aguiar Junior, Pedro De-Marchi, Rafael Paes, Isabella Favato, Gabriela Monte, Tatiane Montella, Filipe Visani, Nathalia Afonso, Izabella Negreiros, Rodrigo Dienstmann, Carlos Gil Ferreira
Publikováno v:
Brazilian Journal of Oncology, Vol 19 (2023)
INTRODUCTION: Immunotherapy led to increased survival in advanced non-small cell lung cancer; however, it has also increased treatment costs. In this study, real-world data was used to evaluate the average cost of treatment of patients with lung canc
Externí odkaz:
https://doaj.org/article/d58a627f4c00416da5abac6aa5924ee9
Autor:
Luiz Henrique Araujo, Gilberto de Castro, Clarissa Baldotto, Marcelo Graziano Custódio, Pedro De-Marchi, Aknar Calabrich, Clarissa Mathias, André Santa-Maria, Maíra Takemoto, Helano Freitas
Publikováno v:
Brazilian Journal of Oncology, Vol 16, Iss (2020)
Objectives: Osimertinib is a third-generation EGFR inhibitor with activity against both sensitizing and resistance mutations. Following results of the phase III study, AURA3, which led to the approval of osimertinib worldwide, we have conducted ASTRI
Externí odkaz:
https://doaj.org/article/f72e0e5c961841b8921e5d1237244b99
Autor:
Bruno L. Ferrari, Carlos Gil Ferreira, Márcia Menezes, Pedro De Marchi, Jorge Canedo, Andréia Cristina de Melo, Alexandre A. Jácome, Tomás Reinert, Rafael Duarte Paes, Bárbara Sodré, Carlos H. Barrios, Rodrigo Dienstmann
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 46-55 (2021)
PURPOSEThe COVID-19 pandemic remains a public health emergency of global concern. Determinants of mortality in the general population are now clear, but specific data on patients with cancer remain limited, particularly in Latin America.MATERIALS AND
Externí odkaz:
https://doaj.org/article/10ad72b4b6d04a04aabd7a3b9deccbf0
Autor:
Rodrigo Cavagna, Flávia Escremim de Paula, Débora Sant'Anna, Iara Santana, Vinicius D. da Silva, Eduardo C. A. da Silva, Carlos E. Bacchi, José E. Miziara, Josiane M. Dias, Pedro De Marchi, Leticia F. Leal, Rui M. Reis
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 639-645 (2021)
Externí odkaz:
https://doaj.org/article/d6569fa2dd424b5d963c9d4953dd8e74
Autor:
Ricardo Ribeiro Gama, Lidia Maria Rebolho Batista Arantes, Bruna Pereira Sorroche, Pedro De Marchi, Matias Eliseo Melendez, Raiany Santos Carvalho, Marcos Alves de Lima, André Luiz Vettore, André Lopes Carvalho
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Evaluate the biological action of valproic acid in the acetylation of histones and in the methylation of tumor suppressor genes via oral rinse in patients with a previous history of head and neck squamous cell carcinoma (HNSCC). Forty-two ac
Externí odkaz:
https://doaj.org/article/a1a750191e93469b91cc45c85575df0e
Autor:
Leticia F. Leal, Ana C. Laus, Rodrigo Cavagna, Flavia E. dePaula, Marco A. deOliveira, Dayana M. Ribeiro, Fernanda M. Hassan, José E. Miziara, Eduardo C. Albino daSilva, Vinicius D. daSilva, Pedro De Marchi, Rui M. Reis
Publikováno v:
Thoracic Cancer, Vol 11, Iss 10, Pp 2987-2992 (2020)
Epidermal growth factor (EGF) and its receptor (EGFR) play a paramount role in lung carcinogenesis. The polymorphism in the EGF promoter region EGF+61A>G (rs4444903) has been associated with cancer susceptibility, but its role in lung cancer patients
Externí odkaz:
https://doaj.org/article/fe78c0c604b747208a6a339545910160
Autor:
Juliano Cé Coelho, Giselle de Souza Carvalho, Fabio Chaves, Pedro de Marchi, Gilberto de Castro Jr, Clarissa Baldotto, Eldsamira Mascarenhas, Patricia Pacheco, Rafaela Gomes, Gustavo Werutsky, Luiz H. Araujo
Publikováno v:
JCO Global Oncology, Vol , Iss 8 (2022)
PURPOSEDespite the advances in the approach to non–small-cell lung cancer (NSCLC) with CNS metastasis, access to timely diagnosis and treatment may not be optimal in many instances. Our main objective was to describe a cohort of patients with NSCLC
Externí odkaz:
https://doaj.org/article/e2d916033adb40cf9ac322b77d9a6785
Autor:
Marina, Kelner, Bruna, Carvalho da Silva, Tatiane, Montella, Pedro Nazareth, Aguiar, Gilberto, Lopes, Carlos G, Ferreira, Pedro, De Marchi
Publikováno v:
Value in Health Regional Issues. 33:1-6
Lung cancer is the leading cause of cancer-related death worldwide, and most patients are diagnosed of advanced disease. Molecular-targeted therapy and immunotherapy increase survival among these patients. In this study, we compared the cost of the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09aa1decebf5e1f7f81b41765fbeb76
https://doi.org/10.1016/j.vhri.2022.08.004
https://doi.org/10.1016/j.vhri.2022.08.004
Autor:
Eduardo Cronemberger, Clarissa Baldotto, Felipe Marinho, Pedro De Marchi, Luiz Henrique Araújo, Fabio Franke, Paulo Salles, Aknar Calabrich, Thaís Almeida, Marcelo Graziano Custodio, André Santa Maria, Marcelo Horacio Pereira, Gilberto Castro Jr
Publikováno v:
Clinics, Vol 75 (2020)
OBJECTIVES: To evaluate the molecular testing and treatment patterns in a retrospective cohort of newly diagnosed treatment-naïve patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC). METHODS: This is an observational retr
Externí odkaz:
https://doaj.org/article/913d911b4f4d48c5b8661e8c2d1f1463
Autor:
Rebeca Silveira Grasel, Paula Silva Felicio, André Escremim de Paula, Natalia Campacci, Felipe Antônio de Oliveira Garcia, Edilene Santos de Andrade, Adriane Feijó Evangelista, Gabriela Carvalho Fernandes, Cristina da Silva Sabato, Pedro De Marchi, Cristiano de Pádua Souza, Cláudia Alessandra Andrade de Paula, Giovana Tardin Torrezan, Henrique de Campos Reis Galvão, Dirce Maria Carraro, Edenir Inêz Palmero
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The use of gene panels introduces a new dilemma in the genetics field due to the high frequency of variants of uncertain significance (VUS). The objective of this study was to provide evidence that may help in the classification of these germline var
Externí odkaz:
https://doaj.org/article/9d0b2b6e93ec44d29e8eecba43646e6d